Outcomes of GDPT (gemcitabine, cisplatin, prednisone,thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients.

Ling Li,Yuanyuan Sun,Xin Li,Lei Zhang,Xinhua Wang,Xiaorui Fu,Zhenchang Sun,Xudong Zhang,Zhaoming Li,Jingjing Wu,Hui Yu,Yu Chang,Jiaqin Yan,Xiaolong Wu,Zhiyuan Zhou,Feifei Nan,Tongyu Lin,Mingzhi Zhang,Tian Li

Outcomes of GDPT (gemcitabine, cisplatin, prednisone,thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients.

2020

Ling Li
Yuanyuan Sun
Xin Li
Lei Zhang
Xinhua Wang
Xiaorui Fu
Zhenchang Sun
Xudong Zhang
Zhaoming Li
Jingjing Wu
Hui Yu
Yu Chang
Jiaqin Yan
Xiaolong Wu
Zhiyuan Zhou
Feifei Nan
Tongyu Lin
Mingzhi Zhang
Tian Li

8018Background: Peripheral T-cell lymphoma(PTCL) is highly heterogeneous invasive NHL.There is no consensus standard treatment for it now. So outcomes of GDPT versus CHOP (cyclophosphamide, doxorub...

Keywords:

Thalidomide
Oncology
Internal medicine
Peripheral T-cell lymphoma
CHOP
newly diagnosed
Pathology
Gemcitabine/cisplatin
Prednisone
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations